Concepts (276)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Enterococcus faecium | 19 | 2019 | 32 | 4.780 |
Why?
|
| Gram-Positive Bacterial Infections | 7 | 2017 | 47 | 1.930 |
Why?
|
| Anti-Bacterial Agents | 9 | 2023 | 746 | 1.910 |
Why?
|
| Fimbriae, Bacterial | 9 | 2016 | 24 | 1.820 |
Why?
|
| Bacterial Proteins | 18 | 2023 | 864 | 1.640 |
Why?
|
| Fimbriae Proteins | 6 | 2012 | 15 | 1.370 |
Why?
|
| Biofilms | 9 | 2017 | 42 | 1.180 |
Why?
|
| Cephalosporins | 2 | 2018 | 24 | 1.180 |
Why?
|
| Cross Infection | 6 | 2017 | 141 | 1.000 |
Why?
|
| Enterococcus | 2 | 2017 | 35 | 0.940 |
Why?
|
| Teichoic Acids | 4 | 2017 | 18 | 0.930 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 3 | 2017 | 44 | 0.860 |
Why?
|
| Lipopolysaccharides | 4 | 2017 | 286 | 0.830 |
Why?
|
| Intestinal Mucosa | 3 | 2018 | 797 | 0.830 |
Why?
|
| Cell Wall | 6 | 2017 | 66 | 0.810 |
Why?
|
| Immunity, Mucosal | 1 | 2018 | 69 | 0.620 |
Why?
|
| Biosynthetic Pathways | 1 | 2017 | 10 | 0.600 |
Why?
|
| Drug Synergism | 1 | 2017 | 303 | 0.570 |
Why?
|
| Anti-Infective Agents | 1 | 2017 | 89 | 0.560 |
Why?
|
| Bacillus cereus | 2 | 2012 | 10 | 0.550 |
Why?
|
| Dysbiosis | 1 | 2015 | 70 | 0.510 |
Why?
|
| Gram-Positive Bacteria | 2 | 2013 | 18 | 0.510 |
Why?
|
| Colon | 1 | 2018 | 496 | 0.500 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2013 | 71 | 0.470 |
Why?
|
| Adhesins, Bacterial | 2 | 2013 | 36 | 0.470 |
Why?
|
| Staphylococcus aureus | 5 | 2016 | 263 | 0.460 |
Why?
|
| Membrane Proteins | 7 | 2015 | 1196 | 0.450 |
Why?
|
| Microbial Sensitivity Tests | 5 | 2023 | 143 | 0.430 |
Why?
|
| Gene Expression Regulation, Bacterial | 7 | 2015 | 204 | 0.420 |
Why?
|
| Staphylococcal Infections | 4 | 2023 | 255 | 0.410 |
Why?
|
| Aminoacyltransferases | 1 | 2011 | 9 | 0.400 |
Why?
|
| Cysteine Endopeptidases | 1 | 2011 | 87 | 0.390 |
Why?
|
| Enterococcus faecalis | 3 | 2017 | 46 | 0.370 |
Why?
|
| Community-Acquired Infections | 1 | 2010 | 63 | 0.360 |
Why?
|
| Bacterial Adhesion | 7 | 2016 | 84 | 0.350 |
Why?
|
| Virulence Factors | 5 | 2023 | 108 | 0.340 |
Why?
|
| Bacterial Outer Membrane Proteins | 2 | 2014 | 53 | 0.330 |
Why?
|
| Organoids | 2 | 2019 | 61 | 0.330 |
Why?
|
| Oxidoreductases | 1 | 2008 | 112 | 0.320 |
Why?
|
| Gene Transfer, Horizontal | 2 | 2023 | 35 | 0.320 |
Why?
|
| Nisin | 2 | 2017 | 4 | 0.290 |
Why?
|
| Mucus | 3 | 2016 | 19 | 0.260 |
Why?
|
| Microscopy, Electron, Transmission | 5 | 2015 | 134 | 0.260 |
Why?
|
| Multigene Family | 5 | 2023 | 202 | 0.260 |
Why?
|
| Molecular Sequence Data | 7 | 2015 | 3030 | 0.250 |
Why?
|
| N-Acetylmuramoyl-L-alanine Amidase | 3 | 2013 | 11 | 0.250 |
Why?
|
| Animals | 15 | 2019 | 26582 | 0.240 |
Why?
|
| Agglutination | 2 | 2015 | 17 | 0.240 |
Why?
|
| Genome, Bacterial | 3 | 2010 | 139 | 0.230 |
Why?
|
| Bacteroides | 1 | 2023 | 33 | 0.230 |
Why?
|
| Probiotics | 2 | 2016 | 81 | 0.230 |
Why?
|
| Klebsiella Infections | 1 | 2023 | 25 | 0.230 |
Why?
|
| Klebsiella pneumoniae | 1 | 2023 | 34 | 0.230 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2019 | 455 | 0.230 |
Why?
|
| DNA, Bacterial | 4 | 2013 | 236 | 0.220 |
Why?
|
| Calcium | 2 | 2019 | 1156 | 0.220 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2023 | 73 | 0.210 |
Why?
|
| Temperature | 4 | 2015 | 396 | 0.210 |
Why?
|
| Sepsis | 3 | 2015 | 306 | 0.200 |
Why?
|
| Membrane Glycoproteins | 3 | 2016 | 428 | 0.200 |
Why?
|
| Humans | 26 | 2023 | 86617 | 0.200 |
Why?
|
| Mice | 9 | 2019 | 11352 | 0.200 |
Why?
|
| Genomic Islands | 2 | 2011 | 14 | 0.190 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 879 | 0.190 |
Why?
|
| Animal Feed | 1 | 2019 | 20 | 0.180 |
Why?
|
| Feces | 3 | 2019 | 319 | 0.180 |
Why?
|
| Genes, Bacterial | 3 | 2012 | 198 | 0.180 |
Why?
|
| Peritoneum | 1 | 2019 | 57 | 0.170 |
Why?
|
| Fibrinogen | 2 | 2016 | 56 | 0.170 |
Why?
|
| Peritoneal Dialysis | 1 | 2019 | 32 | 0.170 |
Why?
|
| Abdominal Wall | 1 | 2019 | 30 | 0.170 |
Why?
|
| Peptidoglycan | 3 | 2015 | 31 | 0.170 |
Why?
|
| Gastrectomy | 1 | 2019 | 68 | 0.170 |
Why?
|
| Mouth Mucosa | 1 | 2019 | 67 | 0.170 |
Why?
|
| Dietary Supplements | 1 | 2019 | 128 | 0.170 |
Why?
|
| Cryptosporidium | 1 | 2018 | 4 | 0.170 |
Why?
|
| Cryptosporidiosis | 1 | 2018 | 6 | 0.170 |
Why?
|
| Gastric Bypass | 1 | 2019 | 110 | 0.160 |
Why?
|
| Penis | 1 | 2018 | 57 | 0.160 |
Why?
|
| Urethra | 1 | 2018 | 113 | 0.150 |
Why?
|
| Depsipeptides | 1 | 2017 | 29 | 0.150 |
Why?
|
| Microbial Interactions | 1 | 2016 | 9 | 0.150 |
Why?
|
| Adaptive Immunity | 1 | 2018 | 164 | 0.150 |
Why?
|
| Staphylococcal Vaccines | 1 | 2016 | 15 | 0.140 |
Why?
|
| Vancomycin | 1 | 2017 | 72 | 0.140 |
Why?
|
| Osteomyelitis | 1 | 2016 | 54 | 0.140 |
Why?
|
| Blotting, Western | 4 | 2013 | 782 | 0.140 |
Why?
|
| Antibodies, Bacterial | 1 | 2016 | 95 | 0.140 |
Why?
|
| Mucin-2 | 1 | 2015 | 12 | 0.140 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2015 | 18 | 0.140 |
Why?
|
| Drug Discovery | 1 | 2017 | 103 | 0.140 |
Why?
|
| Uridine Diphosphate N-Acetylmuramic Acid | 1 | 2015 | 1 | 0.140 |
Why?
|
| Models, Animal | 1 | 2017 | 263 | 0.140 |
Why?
|
| Lipopeptides | 1 | 2015 | 16 | 0.130 |
Why?
|
| Microscopy, Atomic Force | 2 | 2013 | 52 | 0.130 |
Why?
|
| Prophages | 1 | 2015 | 3 | 0.130 |
Why?
|
| Blood Platelets | 1 | 2015 | 149 | 0.130 |
Why?
|
| Fibronectins | 1 | 2015 | 93 | 0.130 |
Why?
|
| Virus Release | 1 | 2015 | 6 | 0.130 |
Why?
|
| Quorum Sensing | 1 | 2015 | 26 | 0.130 |
Why?
|
| Endocarditis, Bacterial | 1 | 2015 | 33 | 0.130 |
Why?
|
| Virulence | 3 | 2011 | 271 | 0.130 |
Why?
|
| Cadherins | 1 | 2015 | 151 | 0.130 |
Why?
|
| Precision Medicine | 1 | 2019 | 395 | 0.130 |
Why?
|
| Immunity, Innate | 1 | 2018 | 409 | 0.120 |
Why?
|
| Protein Multimerization | 2 | 2012 | 173 | 0.120 |
Why?
|
| Ctenocephalides | 1 | 2014 | 1 | 0.120 |
Why?
|
| Yersinia pestis | 1 | 2014 | 24 | 0.120 |
Why?
|
| Cell Membrane | 1 | 2017 | 666 | 0.120 |
Why?
|
| RNA, Messenger | 3 | 2008 | 1981 | 0.120 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2013 | 31 | 0.120 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2013 | 268 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 2 | 2012 | 736 | 0.110 |
Why?
|
| Bacillaceae Infections | 1 | 2012 | 1 | 0.110 |
Why?
|
| beta-Lactamases | 2 | 2023 | 52 | 0.110 |
Why?
|
| Small Molecule Libraries | 1 | 2013 | 61 | 0.110 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2012 | 11 | 0.110 |
Why?
|
| Obesity | 1 | 2019 | 963 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1384 | 0.110 |
Why?
|
| Intestines | 1 | 2015 | 411 | 0.110 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 86 | 0.100 |
Why?
|
| Collagen | 2 | 2013 | 269 | 0.100 |
Why?
|
| Bacillus anthracis | 1 | 2012 | 73 | 0.100 |
Why?
|
| Head and Neck Neoplasms | 1 | 2019 | 1052 | 0.100 |
Why?
|
| Protein Subunits | 1 | 2012 | 122 | 0.100 |
Why?
|
| Membrane Transport Proteins | 1 | 2012 | 166 | 0.100 |
Why?
|
| Mammals | 1 | 2013 | 227 | 0.100 |
Why?
|
| Protein Sorting Signals | 1 | 2011 | 43 | 0.100 |
Why?
|
| Bacterial Vaccines | 1 | 2011 | 41 | 0.100 |
Why?
|
| Elapid Venoms | 1 | 2010 | 5 | 0.100 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2010 | 13 | 0.100 |
Why?
|
| Molecular Weight | 1 | 2010 | 332 | 0.090 |
Why?
|
| Microbiota | 1 | 2015 | 381 | 0.090 |
Why?
|
| RNA, Bacterial | 2 | 2007 | 108 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 639 | 0.090 |
Why?
|
| Blotting, Southern | 1 | 2009 | 129 | 0.090 |
Why?
|
| Bacterial Infections | 1 | 2011 | 182 | 0.090 |
Why?
|
| Ampicillin Resistance | 1 | 2009 | 5 | 0.090 |
Why?
|
| Bacterial Typing Techniques | 1 | 2009 | 28 | 0.090 |
Why?
|
| Dog Diseases | 1 | 2009 | 35 | 0.090 |
Why?
|
| Gene Expression | 2 | 2013 | 1284 | 0.090 |
Why?
|
| Disease Reservoirs | 1 | 2009 | 22 | 0.080 |
Why?
|
| Amino Acid Sequence | 2 | 2010 | 2062 | 0.080 |
Why?
|
| Carrier State | 1 | 2009 | 39 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 2436 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 376 | 0.080 |
Why?
|
| Crystallography, X-Ray | 3 | 2016 | 485 | 0.080 |
Why?
|
| Open Reading Frames | 1 | 2007 | 117 | 0.080 |
Why?
|
| Phylogeny | 3 | 2023 | 1137 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 3 | 2015 | 1047 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2014 | 1565 | 0.070 |
Why?
|
| Proteolysis | 2 | 2016 | 100 | 0.070 |
Why?
|
| Hospitals | 1 | 2007 | 294 | 0.060 |
Why?
|
| Protein Binding | 3 | 2015 | 1456 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2006 | 306 | 0.060 |
Why?
|
| Female | 6 | 2019 | 44509 | 0.060 |
Why?
|
| Genomics | 1 | 2009 | 720 | 0.060 |
Why?
|
| Netherlands | 1 | 2023 | 19 | 0.060 |
Why?
|
| Spain | 1 | 2023 | 33 | 0.060 |
Why?
|
| Fluoroquinolones | 1 | 2023 | 22 | 0.060 |
Why?
|
| Binding Sites | 2 | 2016 | 1098 | 0.060 |
Why?
|
| Mutagenesis, Insertional | 2 | 2014 | 111 | 0.060 |
Why?
|
| Microscopy, Electron | 2 | 2012 | 503 | 0.050 |
Why?
|
| Microscopy, Immunoelectron | 2 | 2013 | 29 | 0.050 |
Why?
|
| Gene Deletion | 2 | 2012 | 329 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2007 | 1351 | 0.050 |
Why?
|
| Cloning, Molecular | 2 | 2013 | 646 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2016 | 1286 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2019 | 78 | 0.040 |
Why?
|
| Base Sequence | 2 | 2015 | 2330 | 0.040 |
Why?
|
| Cadaver | 1 | 2019 | 185 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 187 | 0.040 |
Why?
|
| Cetuximab | 1 | 2019 | 113 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 241 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2019 | 252 | 0.040 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2018 | 21 | 0.040 |
Why?
|
| Species Specificity | 2 | 2011 | 678 | 0.040 |
Why?
|
| Carboplatin | 1 | 2019 | 286 | 0.040 |
Why?
|
| Organ Culture Techniques | 1 | 2018 | 135 | 0.040 |
Why?
|
| Weight Loss | 1 | 2019 | 229 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 458 | 0.040 |
Why?
|
| Biodiversity | 1 | 2019 | 197 | 0.040 |
Why?
|
| Models, Biological | 2 | 2018 | 1749 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2011 | 679 | 0.040 |
Why?
|
| Phantoms, Imaging | 1 | 2019 | 429 | 0.040 |
Why?
|
| Mutation | 3 | 2013 | 3967 | 0.040 |
Why?
|
| Cisplatin | 1 | 2019 | 612 | 0.040 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2016 | 12 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2019 | 695 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 217 | 0.040 |
Why?
|
| Bariatric Surgery | 1 | 2019 | 194 | 0.040 |
Why?
|
| Chemoradiotherapy | 1 | 2019 | 301 | 0.040 |
Why?
|
| Protein Stability | 1 | 2016 | 99 | 0.040 |
Why?
|
| Intestine, Small | 1 | 2018 | 303 | 0.030 |
Why?
|
| Laminin | 1 | 2016 | 85 | 0.030 |
Why?
|
| Tryptophan | 1 | 2016 | 90 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 456 | 0.030 |
Why?
|
| Antigens, Bacterial | 1 | 2016 | 134 | 0.030 |
Why?
|
| Protein Domains | 1 | 2016 | 128 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2015 | 173 | 0.030 |
Why?
|
| Male | 4 | 2019 | 40958 | 0.030 |
Why?
|
| Unilamellar Liposomes | 1 | 2015 | 4 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 2 | 2009 | 853 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2016 | 416 | 0.030 |
Why?
|
| Drug Stability | 1 | 2015 | 48 | 0.030 |
Why?
|
| Biopsy | 1 | 2019 | 1162 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 2232 | 0.030 |
Why?
|
| Middle Aged | 3 | 2019 | 25017 | 0.030 |
Why?
|
| Ciprofloxacin | 1 | 2015 | 29 | 0.030 |
Why?
|
| Ligands | 1 | 2016 | 433 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2015 | 123 | 0.030 |
Why?
|
| Protein Folding | 1 | 2016 | 282 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2015 | 297 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2016 | 456 | 0.030 |
Why?
|
| Phosphatidylglycerols | 1 | 2013 | 5 | 0.030 |
Why?
|
| Drug Resistance, Microbial | 1 | 2013 | 72 | 0.030 |
Why?
|
| Cell Fractionation | 1 | 2013 | 71 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2013 | 77 | 0.030 |
Why?
|
| DNA Transposable Elements | 1 | 2014 | 169 | 0.030 |
Why?
|
| Acyltransferases | 1 | 2013 | 41 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2016 | 971 | 0.030 |
Why?
|
| Bacterial Capsules | 1 | 2012 | 28 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2013 | 156 | 0.030 |
Why?
|
| Crystallization | 1 | 2013 | 206 | 0.030 |
Why?
|
| Spores, Bacterial | 1 | 2012 | 18 | 0.030 |
Why?
|
| Microbial Viability | 1 | 2012 | 31 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 937 | 0.030 |
Why?
|
| Coagulants | 1 | 2011 | 7 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 408 | 0.030 |
Why?
|
| Lung | 1 | 2018 | 1170 | 0.030 |
Why?
|
| Antithrombins | 1 | 2011 | 12 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 95 | 0.030 |
Why?
|
| Coagulase | 1 | 2011 | 25 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 2011 | 37 | 0.030 |
Why?
|
| Immunization, Passive | 1 | 2011 | 71 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2014 | 191 | 0.030 |
Why?
|
| Longevity | 1 | 2011 | 51 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 214 | 0.030 |
Why?
|
| Conjugation, Genetic | 1 | 2011 | 22 | 0.030 |
Why?
|
| Protein Transport | 1 | 2012 | 411 | 0.020 |
Why?
|
| Bacillus megaterium | 1 | 2010 | 1 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2011 | 112 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2010 | 117 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2010 | 102 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2010 | 135 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2011 | 152 | 0.020 |
Why?
|
| Adult | 2 | 2019 | 25640 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 188 | 0.020 |
Why?
|
| Bacteriophages | 1 | 2010 | 47 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2010 | 178 | 0.020 |
Why?
|
| Computational Biology | 1 | 2013 | 528 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1920 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2010 | 315 | 0.020 |
Why?
|
| Denmark | 1 | 2009 | 15 | 0.020 |
Why?
|
| DNA Fingerprinting | 1 | 2009 | 16 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2011 | 231 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 268 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 1538 | 0.020 |
Why?
|
| Myocardium | 1 | 2011 | 529 | 0.020 |
Why?
|
| United Kingdom | 1 | 2009 | 164 | 0.020 |
Why?
|
| Heart | 1 | 2011 | 539 | 0.020 |
Why?
|
| Rats | 1 | 2015 | 3990 | 0.020 |
Why?
|
| Dogs | 1 | 2009 | 685 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2011 | 673 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2010 | 881 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1753 | 0.020 |
Why?
|
| Anaerobiosis | 1 | 2006 | 22 | 0.020 |
Why?
|
| Aerobiosis | 1 | 2006 | 17 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 3092 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2006 | 238 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2011 | 926 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 1019 | 0.020 |
Why?
|
| Phenotype | 1 | 2011 | 2378 | 0.020 |
Why?
|
| Genotype | 1 | 2009 | 1851 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2009 | 1621 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 18402 | 0.010 |
Why?
|